Literature DB >> 7106156

An assessment of short-cut procedures for studying drug metabolism in vivo using amobarbital as a model drug.

B K Tang, W Kalow, L Endrenyi, F Y Chan.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7106156     DOI: 10.1007/BF00545220

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

Review 1.  Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.

Authors:  J R Idle; R L Smith
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

2.  Distinctive patterns of amobarbital metabolites.

Authors:  W Kalow; B K Tang; D Kadar; T Inaba
Journal:  Clin Pharmacol Ther       Date:  1978-11       Impact factor: 6.875

3.  A multi-dose study on the human metabolism of amylobarbitone.

Authors:  W C Baldeo; J N Gilbert; J W Powell
Journal:  Xenobiotica       Date:  1979-04       Impact factor: 1.908

4.  A method for studying drug metabolism in populations: racial differences in amobarbital metabolism.

Authors:  W Kalow; B K Tang; D Kadar; L Endrenyi; F Y Chan
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

5.  Deficient metabolism of debrisoquine and sparteine.

Authors:  T Inaba; S V Otton; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

6.  A case of deficiency of N-hydroxylation of amobarbital.

Authors:  W Kalow; D Kadar; T Inaba; B K Tang
Journal:  Clin Pharmacol Ther       Date:  1977-05       Impact factor: 6.875

  6 in total
  2 in total

1.  Stereochemical characterization of the diastereomers of the amobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; F C Wireko; D J Abraham
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.